Clinical Trial Update: Ex Vivo Immunotherapy for Hyperglycemia in Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating ex vivo immunotherapy for hyperglycemia in Type 2 Diabetes Mellitus has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperglycemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Ex Vivo Immunotherapy

Snippet

Sponsor: B & Y Technologies | Conditions: Type 2 Diabetes Mellitus, Hyperglycemia | Phase 1 | Status: COMPLETED